Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D'atri

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Arzneimittel-Forschung|April 1, 1976
Urinary metabolites of 2-formyl-17 alpha-methylandrosta-1,4-diene-11alpha, 17beta-dihydroxy-3-one in the ratG De Marchi, G d'Atri, C Scolastico
MMW, Munchener Medizinische Wochenschrift|February 6, 1976
[Antiedema activity of a non-steroid physiological anti-inflammatory agent (author's transl)]P Gomarasca, G d'Atri, S Cerutti, et al.
Arzneimittel-Forschung|January 1, 1976
Histopathological and pharmacological studies on the action of a new anti-inflammatory agent (BR 700)E Galimberti, S Cerutti, A Forlani, et al.
Arzneimittel-Forschung|September 1, 1986
Androstane derivative devoid of anabolic-virilizing effects and endowed with an antiglucocorticoid activityF Berti, P Gomarasca, C Frova, et al.
Journal of Pharmacological and Toxicological Methods|March 1, 1997
Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugsF Di Pierro, G d'Atri, F Marcucci, et al.
Atherosclerosis|November 1, 1980
Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley ratsG D'Atri, P Gomarasca, E Galimberti, et al.
Atherosclerosis|May 1, 1978
Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteinsC R Sirtori, P Gomarasca, G D'Atri, et al.
Journal of Medicinal Chemistry|December 1, 1984
Novel pyrimidine and 1,3,5-triazine hypolipidemic agentsG d'Atri, P Gomarasca, G Resnati, et al.
Journal of Medicinal Chemistry|June 20, 1997
A new rational hypothesis for the pharmacophore of the active metabolite of leflunomide, a potent immunosuppressive drugG Bertolini, M Aquino, M Biffi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Arzneimittel-Forschung|April 1, 1976
Urinary metabolites of 2-formyl-17 alpha-methylandrosta-1,4-diene-11alpha, 17beta-dihydroxy-3-one in the ratG De Marchi, G d'Atri, C Scolastico
MMW, Munchener Medizinische Wochenschrift|February 6, 1976
[Antiedema activity of a non-steroid physiological anti-inflammatory agent (author's transl)]P Gomarasca, G d'Atri, S Cerutti, et al.
Arzneimittel-Forschung|January 1, 1976
Histopathological and pharmacological studies on the action of a new anti-inflammatory agent (BR 700)E Galimberti, S Cerutti, A Forlani, et al.
Arzneimittel-Forschung|September 1, 1986
Androstane derivative devoid of anabolic-virilizing effects and endowed with an antiglucocorticoid activityF Berti, P Gomarasca, C Frova, et al.
Journal of Pharmacological and Toxicological Methods|March 1, 1997
Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugsF Di Pierro, G d'Atri, F Marcucci, et al.
Atherosclerosis|November 1, 1980
Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley ratsG D'Atri, P Gomarasca, E Galimberti, et al.
Atherosclerosis|May 1, 1978
Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteinsC R Sirtori, P Gomarasca, G D'Atri, et al.
Journal of Medicinal Chemistry|December 1, 1984
Novel pyrimidine and 1,3,5-triazine hypolipidemic agentsG d'Atri, P Gomarasca, G Resnati, et al.
Journal of Medicinal Chemistry|June 20, 1997
A new rational hypothesis for the pharmacophore of the active metabolite of leflunomide, a potent immunosuppressive drugG Bertolini, M Aquino, M Biffi, et al.
Pageof 1